186 related articles for article (PubMed ID: 11720435)
41. p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent.
Ichimiya S; Nimura Y; Kageyama H; Takada N; Sunahara M; Shishikura T; Nakamura Y; Sakiyama S; Seki N; Ohira M; Kaneko Y; McKeon F; Caput D; Nakagawara A
Oncogene; 1999 Jan; 18(4):1061-6. PubMed ID: 10023682
[TBL] [Abstract][Full Text] [Related]
42. Relationship between p73 polymorphism and the immunohistochemical profile of the full-length (TAp73) and NH2-truncated (ΔNp73) isoforms in Tunisian patients.
Arfaoui AT; Ben Mahmoud LK; Ben Hmida A; Khiari M; Mohamed AL; Chaar I; Khalfallah T; Regaya SM; Bouraoui S
Appl Immunohistochem Mol Morphol; 2010 Dec; 18(6):546-54. PubMed ID: 20733477
[TBL] [Abstract][Full Text] [Related]
43. Absence of mutation of the p73 gene localized at chromosome 1p36.3 in hepatocellular carcinoma.
Mihara M; Nimura Y; Ichimiya S; Sakiyama S; Kajikawa S; Adachi W; Amano J; Nakagawara A
Br J Cancer; 1999 Jan; 79(1):164-7. PubMed ID: 10408709
[TBL] [Abstract][Full Text] [Related]
44. Genetic variants of the p53 and p73 genes jointly increase risk of second primary malignancies in patients after index squamous cell carcinoma of the head and neck.
Zhang Y; Sturgis EM; Huang Z; Zafereo ME; Wei Q; Li G
Cancer; 2012 Jan; 118(2):485-92. PubMed ID: 21717430
[TBL] [Abstract][Full Text] [Related]
45. Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family.
Flores ER; Sengupta S; Miller JB; Newman JJ; Bronson R; Crowley D; Yang A; McKeon F; Jacks T
Cancer Cell; 2005 Apr; 7(4):363-73. PubMed ID: 15837625
[TBL] [Abstract][Full Text] [Related]
46. Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer: evidence for a crucial p53-p73 cross-talk in vivo.
Concin N; Hofstetter G; Berger A; Gehmacher A; Reimer D; Watrowski R; Tong D; Schuster E; Hefler L; Heim K; Mueller-Holzner E; Marth C; Moll UM; Zeimet AG; Zeillinger R
Clin Cancer Res; 2005 Dec; 11(23):8372-83. PubMed ID: 16322298
[TBL] [Abstract][Full Text] [Related]
47. Association of p53 codon Arg72Pro and p73 G4C14-to-A4T14 at exon 2 genetic polymorphisms with the risk of Japanese breast cancer.
Huang XE; Hamajima N; Katsuda N; Matsuo K; Hirose K; Mizutani M; Iwata H; Miura S; Xiang J; Tokudome S; Tajima K
Breast Cancer; 2003; 10(4):307-11. PubMed ID: 14634508
[TBL] [Abstract][Full Text] [Related]
48. Combined effect of genetic polymorphisms in P53, P73, and MDM2 on non-small cell lung cancer survival.
Liu L; Wu C; Wang Y; Zhong R; Duan S; Wei S; Lin S; Zhang X; Tan W; Yu D; Nie S; Miao X; Lin D
J Thorac Oncol; 2011 Nov; 6(11):1793-800. PubMed ID: 21841506
[TBL] [Abstract][Full Text] [Related]
49. Down-regulation of p73 correlates with high histological grade in Japanese with breast carcinomas.
Du CW; Kimijima I; Otake T; Abe R; Takenoshita S; Zhang GJ
Chin Med J (Engl); 2011 Aug; 124(15):2275-8. PubMed ID: 21933556
[TBL] [Abstract][Full Text] [Related]
50. Manganese superoxide dismutase (MnSOD) polymorphism, alcohol, cigarette smoking and risk of oesophageal cancer.
Sun L; König IR; Homann N
Alcohol Alcohol; 2009; 44(4):353-7. PubMed ID: 19451660
[TBL] [Abstract][Full Text] [Related]
51. P53, p21, and p73 gene polymorphisms in gastric carcinoma.
Shirai O; Ohmiya N; Taguchi A; Nakamura M; Kawashima H; Miyahara R; Itoh A; Hirooka Y; Watanabe O; Ando T; Goto Y; Hamajima N; Goto H
Hepatogastroenterology; 2010; 57(104):1595-601. PubMed ID: 21443127
[TBL] [Abstract][Full Text] [Related]
52. Mutation analysis of P73 and TP53 in Merkel cell carcinoma.
Van Gele M; Kaghad M; Leonard JH; Van Roy N; Naeyaert JM; Geerts ML; Van Belle S; Cocquyt V; Bridge J; Sciot R; De Wolf-Peeters C; De Paepe A; Caput D; Speleman F
Br J Cancer; 2000 Feb; 82(4):823-6. PubMed ID: 10732753
[TBL] [Abstract][Full Text] [Related]
53. Role of functional polymorphisms of P53 and P73 genes with the risk of prostate cancer in a case-control study from Northern India.
Mittal RD; George GP; Mishra J; Mittal T; Kapoor R
Arch Med Res; 2011 Feb; 42(2):122-7. PubMed ID: 21565625
[TBL] [Abstract][Full Text] [Related]
54. Germline mutations in the p73 gene do not predispose to familial prostate-brain cancer.
Peters MA; Janer M; Kolb S; Jarvik GP; Ostrander EA; Stanford JL
Prostate; 2001 Sep; 48(4):292-6. PubMed ID: 11536309
[TBL] [Abstract][Full Text] [Related]
55. Polymorphisms of p53 Arg72Pro, p73 G4C14-to-A4T14 at exon 2 and p21 Ser31Arg and the risk of non-Hodgkin's lymphoma in Japanese.
Hishida A; Matsuo K; Tajima K; Ogura M; Kagami Y; Taji H; Morishima Y; Emi N; Naoe T; Hamajima N
Leuk Lymphoma; 2004 May; 45(5):957-64. PubMed ID: 15291355
[TBL] [Abstract][Full Text] [Related]
56. Combined effects of the p53 and p73 polymorphisms on lung cancer risk.
Schabath MB; Wu X; Wei Q; Li G; Gu J; Spitz MR
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):158-61. PubMed ID: 16434604
[TBL] [Abstract][Full Text] [Related]
57. Association of p73 G4C14-A4T14 and p53 codon 72 polymorphism with cervical cancer in Chinese population.
Guo H; Wen Z; Yang S; Qi H
Indian J Cancer; 2022; 59(1):33-38. PubMed ID: 34380847
[TBL] [Abstract][Full Text] [Related]
58. The p73 locus is commonly deleted in non-Hodgkin's lymphomas.
Stoffel A; Filippa D; Rao PH
Leuk Res; 2004 Dec; 28(12):1341-5. PubMed ID: 15475076
[TBL] [Abstract][Full Text] [Related]
59. p73 G4C14 to A4T14 polymorphism is associated with colorectal cancer risk and survival.
Lee KE; Hong YS; Kim BG; Kim NY; Lee KM; Kwak JY; Roh MS
World J Gastroenterol; 2010 Sep; 16(35):4448-54. PubMed ID: 20845513
[TBL] [Abstract][Full Text] [Related]
60. Genetic polymorphisms of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro and the risk of cervical cancer in Japanese.
Niwa Y; Hamajima N; Atsuta Y; Yamamoto K; Tamakoshi A; Saito T; Hirose K; Nakanishi T; Nawa A; Kuzuya K; Tajima K
Cancer Lett; 2004 Mar; 205(1):55-60. PubMed ID: 15036661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
